Effect of treatment with copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomyelitis (EAE)
- 1 December 1983
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 62 (1-3), 281-293
- https://doi.org/10.1016/0022-510x(83)90205-8
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Multiple sclerosis: Trial of a synthetic polypeptideAnnals of Neurology, 1982
- Experimental Allergic Encephalomyelitis ‐ Susceptibility and SuppressionImmunological Reviews, 1981
- Multiple sclerosisNeurology, 1980
- Proteinase inhibitors suppress the development of experimental allergic encephalomyelitisNature, 1980
- The effect of Cop 1, a synthetic polypeptide, on chronic relapsing experimental allergic encephalomyelitis in guinea pigsJournal of the Neurological Sciences, 1979
- Treatment of experimental allergic encephalomyelitis with an inhibitor of cathepsin D (pepstatin)Neurochemical Research, 1978
- Effect of a synthetic polypeptide (Cop 1) on patients with multiple sclerosis and with acute disseminated encephalomyelitisJournal of the Neurological Sciences, 1977
- In vitro and in vivo immune responses to homologous myelin basic protein in experimental allergic encephalomyelitisCellular Immunology, 1974
- Large Scale Preparation of Myelin Basic Protein from Central Nervous Tissue of Several Mammalian SpeciesPreparative Biochemistry, 1972
- Clinico-Pathologic Correlations in Experimental Allergic EncephalomyelitisJournal of Neuropathology and Experimental Neurology, 1959